MiNK Therapeutics, Inc. Business Finance Contracts & Agreements

19 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Stock Purchase Agreement between MiNK Therapeutics, Inc. and Investor (May 13, 2024)
Purchase Agreements
MiNK Therapeutics, Inc.
Biotechnology
DE
2024
Convertible Promissory Note Purchase Agreement between MiNK Therapeutics, Inc. and Agenus Inc. dated February 12, 2024
Note Agreements
MiNK Therapeutics, Inc.
Biotechnology
DE
2024
MiNK Therapeutics, Inc. Convertible Promissory Note with Agenus Inc. (Up to $5,000,000)
Note Agreements
MiNK Therapeutics, Inc.
Biotechnology
MA
2024
Description of MiNK Therapeutics, Inc. Common Stock Registered Under Section 12 of the Exchange Act
Stock Agreements
MiNK Therapeutics, Inc.
Biotechnology
2022
MiNK Therapeutics, Inc. 2021 Equity Incentive Plan Incentive Stock Option Agreement with Participant
Warrant Agreements
MiNK Therapeutics, Inc.
Biotechnology
2021
MiNK Therapeutics, Inc. 2021 Equity Incentive Plan Non-Statutory Stock Option Agreement
Warrant Agreements
MiNK Therapeutics, Inc.
Biotechnology
2021
MiNK Therapeutics, Inc. 2021 Equity Incentive Plan Restricted Stock Unit Agreement
Equity Distribution Agreements
MiNK Therapeutics, Inc.
Biotechnology
2021
Mink Therapeutics, Inc. 2021 Employee Stock Purchase Plan
Subscription Agreements
MiNK Therapeutics, Inc.
Biotechnology
DE
2021
Mink Therapeutics, Inc. 2021 Equity Incentive Plan
Equity Distribution Agreements
MiNK Therapeutics, Inc.
Biotechnology
DE
2021
Amendment to Convertible Promissory Note between MiNK Therapeutics, Inc. and Agenus Inc.
Note Agreements
MiNK Therapeutics, Inc.
Biotechnology
MA
2021
Common Stock Certificate for Mink Therapeutics, Inc.
Stock Agreements
MiNK Therapeutics, Inc.
Biotechnology
2021
Underwriting Agreement among MiNK Therapeutics, Inc., Agenus Inc., and Underwriters (Evercore, William Blair) for Common Stock Offering
Underwriting Agreements
MiNK Therapeutics, Inc.
Biotechnology
NY
2021
AgenTus Therapeutics, Inc. Restricted Stock Agreement with Patrick Jordan under 2018 Equity Incentive Plan
Stock Agreements
MiNK Therapeutics, Inc.
Biotechnology
2021
AgenTus Therapeutics, Inc. 2018 Equity Incentive Plan Incentive Stock Option Agreement with Grantee
Warrant Agreements
MiNK Therapeutics, Inc.
Biotechnology
2021
AgenTus Therapeutics, Inc. 2018 Equity Incentive Plan Non-Qualified Stock Option Agreement (Non-Employee)
Warrant Agreements
MiNK Therapeutics, Inc.
Biotechnology
2021
AgenTus Therapeutics, Inc. 2018 Equity Incentive Plan Non-Qualified Stock Option Agreement with Grantee
Warrant Agreements
MiNK Therapeutics, Inc.
Biotechnology
2021
AgenTus Therapeutics, Inc. 2018 Equity Incentive Plan Restricted Stock Agreement with Grantee
Stock Agreements
MiNK Therapeutics, Inc.
Biotechnology
2021
Convertible Promissory Note Purchase Agreement between AgenTus Therapeutics, Inc. and Agenus Inc. dated February 11, 2021
Note Agreements
MiNK Therapeutics, Inc.
Biotechnology
DE
2021
AgenTus Therapeutics, Inc. Convertible Promissory Note with Agenus Inc. (Up to $50,000,000)
Note Agreements
MiNK Therapeutics, Inc.
Biotechnology
MA
2021